Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTM2 | P28161 | 1/20 | 0.57 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.47 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.47 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.47 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MYC | P01106 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6759054 | 0.95 | GSTM2 (0.56) | GSTM2HRH3KDM4EMAPTS1PR1 | |
| SCHEMBL17240248 | 0.94 | S1PR1 (0.56) | GSTM2HRH3KDM4EMAPTS1PR1 | |
| SCHEMBL12272715 | 0.94 | S1PR1 (0.56) | GSTM2HRH3KDM4EMAPTS1PR1 | |
| SCHEMBL15500035 | 0.94 | S1PR1 (0.56) | GSTM2HRH3KDM4EMAPTS1PR1 | |
| SCHEMBL31751965 | 0.91 | PRKCA (0.55) | GSTM2HRH3KDM4EMAPTS1PR1 | |
| SCHEMBL3424607 | 0.91 | PRKCA (0.55) | GSTM2HRH3KDM4EMAPTS1PR1 | |
| SCHEMBL6759014 | 0.90 | GSTM2 (0.57) | GSTM2HRH3KDM4EMAPTS1PR1 | |
| SCHEMBL6763510 | 0.89 | GSTM2 (0.53) | GSTM2HRH3KDM4EMAPTS1PR1 | |
| SCHEMBL4222844 | 0.89 | FABP3 (0.50) | GSTM2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL6510371 | 0.89 | S1PR1 (0.48) | GSTM2HRH3S1PR1S1PR3S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6783949-B1 | REACTING FLUORESCENTLY LABELED FATTY ACID WITH 2,3-EPOXYPROPANOL TO FORM MONOGLYCERIDE WHICH IS SUBJECTED TO ULTRASONIC TREATMENT WITH PHOSPHOLIPIDS; DRUG SCREENING; FOR DETECTING METABOLIC DISORDERS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-08-31 | — | — | US | disclosed |